The association between the variations of these genes and breast cancer has been corroborated by research, such as the identification of the polymorphism of tissue inhibitor of metalloproteinase-2 (TIMP-2) as a risk factor for breast cancer [6]. This evidence concerns the gene TIMP2 and breast carcinoma.